(Q81688189)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18649080%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

EANM procedure guideline for treatment of refractory metastatic bone pain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18649080%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18649080%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Glenn D Flux

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18649080%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Arturo Chiti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18649080%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Lisa Bodei

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18649080%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Marnix Lam

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18649080%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Boudewijn Brans

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18649080%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Francesco Giammarile

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18649080%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

European Association of Nuclear Medicine (EANM)

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18649080%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18649080%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

number of pages

7

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18649080%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18649080%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18649080%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

1934-1940

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18649080%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-008-0841-y

11 January 2020

exact match

0 references

cites work

Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer

1 reference

12 December 2020

Disseminated intravascular coagulation in a patient treated with strontium-89 for metastatic carcinoma of the prostate

1 reference

12 December 2020

Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary Group.

1 reference

12 December 2020

A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases.

1 reference

12 December 2020

Strontium-89 treatment for prostate cancer bone metastases: does a prostate-specific antigen response predict for improved survival?

1 reference

12 December 2020

Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain

1 reference

12 December 2020

[Treatment of metastatic bone pain with repeated doses of strontium-89 in patients with prostate neoplasm]

1 reference

12 December 2020

Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancer

1 reference

12 December 2020

A retrospective analysis of the cost effectiveness of treatment with Metastron (89Sr-chloride) in patients with prostate cancer metastatic to bone

1 reference

12 December 2020

Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial

1 reference

12 December 2020

Predictors of response to strontium-89 (Metastron) in skeletal metastases from prostate cancer: report of a single centre's 10-year experience

1 reference

12 December 2020

Samarium-153-EDTMP: pharmacokinetic, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer

1 reference

12 December 2020

Samarium-153-EDTMP biodistribution and dosimetry estimation

1 reference

12 December 2020

Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer.

1 reference

12 December 2020

A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer

1 reference

12 December 2020

Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. Administration of Radioactive Substances Advisory Committee

1 reference

12 December 2020

A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases

1 reference

12 December 2020

Strontium-89: treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone.

1 reference

12 December 2020

Radioisotopes for the palliation of metastatic bone cancer: a systematic review

1 reference

12 December 2020

Radiation dose to patients from radiopharmaceuticals. A report of a Task Group of Committee 2 of the International Commission on Radiological Protection

1 reference

12 December 2020

Radionuclides for metastatic bone pain palliation: a need for rational re-evaluation in the new millennium

1 reference

12 December 2020

Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases

1 reference

12 December 2020

Variation in oncologic opinion regarding management of metastatic bone pain with systemic radionuclide therapy.

1 reference

12 December 2020

Use of bone scintigraphy to select patients with multiple myeloma for treatment with strontium-89.

1 reference

12 December 2020

The palliative management of skeletal metastases in prostate cancer: use of bone-seeking radionuclides and bisphosphonates

1 reference

12 December 2020

Treatment of metastatic bone pain using the bone seeking radiopharmaceutical Re-186-HEDP.

1 reference

12 December 2020

Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy

1 reference

12 December 2020

Samarium 153Sm lexidronam

1 reference

12 December 2020

Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial.

1 reference

12 December 2020

Strontium-89 for the palliation of bone pain due to metastatic disease

1 reference

12 December 2020

Teletherapy and radiopharmaceutical therapy of painful bone metastases

1 reference

12 December 2020

Bone-seeking radionuclides for therapy

1 reference

12 December 2020

The changing pattern of management for hormone-refractory, metastatic prostate cancer

1 reference

12 December 2020

Malignant bone pain: pathophysiology and treatment

1 reference

12 December 2020

Strontium-89 therapy for the pain of osseous metastases.

1 reference

12 December 2020

10.1007/S00259-008-0841-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18649080%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference